- Home
- SSII vs ATAI Comparison
SSII vs ATAI Comparison
Compare SSII & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSII
- ATAI
- Stock Information
- Founded
- SSII N/A
- ATAI 2018
- Country
- SSII India
- ATAI Netherlands
- Employees
- SSII N/A
- ATAI N/A
- Industry
- SSII
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- SSII
- ATAI Health Care
- Exchange
- SSII Nasdaq
- ATAI Nasdaq
- Market Cap
- SSII 1.3B
- ATAI 1.1B
- IPO Year
- SSII N/A
- ATAI 2021
- Fundamental
- Price
- SSII $5.62
- ATAI $5.42
- Analyst Decision
- SSII
- ATAI Strong Buy
- Analyst Count
- SSII 0
- ATAI 4
- Target Price
- SSII N/A
- ATAI $13.75
- AVG Volume (30 Days)
- SSII 48.6K
- ATAI 5.4M
- Earning Date
- SSII 11-14-2025
- ATAI 11-12-2025
- Dividend Yield
- SSII N/A
- ATAI N/A
- EPS Growth
- SSII N/A
- ATAI N/A
- EPS
- SSII N/A
- ATAI N/A
- Revenue
- SSII $27,623,624.00
- ATAI $2,309,000.00
- Revenue This Year
- SSII N/A
- ATAI $712.99
- Revenue Next Year
- SSII N/A
- ATAI N/A
- P/E Ratio
- SSII N/A
- ATAI N/A
- Revenue Growth
- SSII 134.89
- ATAI 510.85
- 52 Week Low
- SSII $2.48
- ATAI $1.03
- 52 Week High
- SSII $22.42
- ATAI $5.97
- Technical
- Relative Strength Index (RSI)
- SSII 43.96
- ATAI 65.93
- Support Level
- SSII $5.42
- ATAI $5.02
- Resistance Level
- SSII $6.36
- ATAI $5.97
- Average True Range (ATR)
- SSII 0.48
- ATAI 0.31
- MACD
- SSII -0.02
- ATAI 0.03
- Stochastic Oscillator
- SSII 31.25
- ATAI 62.93
About SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.